Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients (ALU)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04412070 |
|
Recruitment Status :
Recruiting
First Posted : June 2, 2020
Last Update Posted : August 31, 2022
|
Sponsor:
Hopital Foch
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Hopital Foch
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 2023 |
| Estimated Study Completion Date : | July 2025 |